TARA: Prakiraan konsensus analis Protara

Protara Therapeutics (TARA) is implementing AI control and closed bioreactors to automate drug synthesis, minimizing manual labor. The humanitarian profile of the business shields its developments from sanctions and geopolitical risks. This price chart demonstrates a consensus forecast of 25.67. Meanwhile, the financial position relies on investments and R&D success, as the company does not yet have regular sales revenue.

TARA: Prakiraan konsensus analis Protara Therapeutics 04.07.2022 - 22.10.2026

Rincian analitis perusahaan Protara (TARA)

Indikator analitis utama Protara Tx (TARA):

Rega protaratx.com|TARA - Prakiraan konsensus analis|Kapitalisasi pasar Protara

Analisis fundamental perusahaan:protaratx.com (TARA)

Produk asli Protara

Strategic alliances between Protara Therapeutics (TARA) and research centers are accelerating the commercialization of bio-assets, directly impacting market expectations regarding business valuation. The trajectory of analysts' target prices aggregates average expert forecasts for the stock's fair value, allowing investors to gauge market confidence in the company's capital through the dynamics of the fundamental revaluation of its prospects.

Perusahaan pesaing

Rega prakiraan analis ONC|Prakiraan konsensus analis HALO (Halozyme)|Prakiraan konsensus analis Revolution Medicines Inc RVMD|AAPG - Bagan rega target|Konsensus nilai wajar CGON (CG Oncology Therapeutics)|URGN: Prakiraan konsensus analis|bicara.com (BCAX) - Prakiraan konsensus analis|PSNL (Personalis) - Prakiraan konsensus analis|Target konsensus Erasca Inc (ERAS)|Prakiraan konsensus analis DCTH|Prakiraan konsensus analis Y-mAbs Corp (YMAB)|Bagan rega target Aura Biosciences, Inc. AURA|CADL: Prakiraan gabungan firma investasi|Accuray - Prakiraan konsensus analis|SELLAS Life Sciences (SLS) - Target konsensus|ACTU: Prakiraan konsensus analis|Rata-rata rega prakiraan Citius Oncology Inc (CTOR)|Bagan rega target TuHURA Biosciences Inc.|FATE: Konsensus nilai wajar|Target konsensus WHWK (Aadi Bioscience Inc)|TCRX (tscan.com) - Konsensus nilai wajar|Prakiraan konsensus analis CSBR (Champions Oncology, Inc.)|XBIT - Target konsensus|CVM: Target konsensus|OSTX - Prakiraan konsensus analis|Radiopharm Theranostics Limited (RADX) - Bagan rega target|Artiva Biotherapeutics - Konsensus nilai wajar|ANL (Adlai Nortye Ltd) - Prakiraan konsensus analis|Rata-rata rega prakiraan Veru Corporation VERU|Bagan rega target Tempest Therapeutics (TPST)|XLO: Bagan tingkat prakiraan|Bagan rega target Renovaro RENB|Konsensus nilai wajar MURA|KAPA - Bagan rega target|Rata-rata rega prakiraan OnKure Therapeutics Inc|GDTC (w2.cytomed.sg) - Target konsensus|CRIS: Rega prakiraan analis|APLM (Apollomics Inc.) - Prakiraan konsensus analis|Prakiraan konsensus analis Tharimmune Inc|Bagan rega target Advanced Biomed Inc (ADVB)|GNPX (Genprex Inc) - Konsensus nilai wajar|Prakiraan konsensus analis CLDI (Calidi Biotherapeutics, Inc.)|Prakiraan konsensus analis Sunshine Biopharma Inc. SBFM|XBIO: Target konsensus|Konsensus nilai wajar SLRX (Salarius Pharmaceuticals Inc)|PPBT (Purple Biotech Corp) - Target konsensus|AONC: Rega prakiraan analis|BGNE (BeiGene, Ltd.) - Prakiraan konsensus analis|CKPT: Konsensus nilai wajar|Prakiraan konsensus analis ELEV|ICAD - Rata-rata rega prakiraan|Bagan rega target Ikena Oncology IKNA|Konsensus nilai wajar NTBL|Viracta - Prakiraan konsensus analis|MOR - Prakiraan konsensus analis|NAYA Biosciences Inc. (NAYA) - Bagan rega target|Bagan tingkat prakiraan AAPGV (Ascentage Pharma Group International)